These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 12508394)

  • 1. Baseline features and initial treatment as predictors of remission and relapse in Wegener's granulomatosis.
    Koldingsnes W; Nossent JC
    J Rheumatol; 2003 Jan; 30(1):80-8. PubMed ID: 12508394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of damage and survival in patients with Wegener's granulomatosis: analysis of 50 patients.
    Kamali S; Erer B; Artim-Esen B; Gul A; Ocal L; Konice M; Aral O; Inanc M
    J Rheumatol; 2010 Feb; 37(2):374-8. PubMed ID: 20008921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients.
    Reinhold-Keller E; Beuge N; Latza U; de Groot K; Rudert H; Nölle B; Heller M; Gross WL
    Arthritis Rheum; 2000 May; 43(5):1021-32. PubMed ID: 10817555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).
    Seo P; Min YI; Holbrook JT; Hoffman GS; Merkel PA; Spiera R; Davis JC; Ytterberg SR; St Clair EW; McCune WJ; Specks U; Allen NB; Luqmani RA; Stone JH;
    Arthritis Rheum; 2005 Jul; 52(7):2168-78. PubMed ID: 15986348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
    De Groot K; Rasmussen N; Bacon PA; Tervaert JW; Feighery C; Gregorini G; Gross WL; Luqmani R; Jayne DR
    Arthritis Rheum; 2005 Aug; 52(8):2461-9. PubMed ID: 16052573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of non-life threatening Wegener's granulomatosis with methotrexate and daily prednisone as the initial therapy of choice.
    Stone JH; Tun W; Hellman DB
    J Rheumatol; 1999 May; 26(5):1134-9. PubMed ID: 10332980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-cell depletion with rituximab for refractory head and neck Wegener's granulomatosis: a cohort study.
    Martinez Del Pero M; Chaudhry A; Jones RB; Sivasothy P; Jani P; Jayne D
    Clin Otolaryngol; 2009 Aug; 34(4):328-35. PubMed ID: 19673980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of remission in Wegener's granulomatosis with low dose methotrexate.
    de Groot K; Mühler M; Reinhold-Keller E; Paulsen J; Gross WL
    J Rheumatol; 1998 Mar; 25(3):492-5. PubMed ID: 9517769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: results of a multicenter, prospective, open-label study of twenty-two patients.
    Martinez V; Cohen P; Pagnoux C; Vinzio S; Mahr A; Mouthon L; Sailler L; Delaunay C; Sadoun A; Guillevin L;
    Arthritis Rheum; 2008 Jan; 58(1):308-17. PubMed ID: 18163506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignancies in Wegener's granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients.
    Faurschou M; Sorensen IJ; Mellemkjaer L; Loft AG; Thomsen BS; Tvede N; Baslund B
    J Rheumatol; 2008 Jan; 35(1):100-5. PubMed ID: 17937462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of survival and organ damage in Wegener's granulomatosis.
    Koldingsnes W; Nossent H
    Rheumatology (Oxford); 2002 May; 41(5):572-81. PubMed ID: 12011383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etanercept plus standard therapy for Wegener's granulomatosis.
    Wegener's Granulomatosis Etanercept Trial (WGET) Research Group
    N Engl J Med; 2005 Jan; 352(4):351-61. PubMed ID: 15673801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome analysis of patients with vasculitis associated with antineutrophil cytoplasmic antibodies.
    Brijker F; Magee CC; Tervaert JW; O'Neill S; Walshe JJ
    Clin Nephrol; 1999 Dec; 52(6):344-51. PubMed ID: 10604641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance of remission with leflunomide in Wegener's granulomatosis.
    Metzler C; Fink C; Lamprecht P; Gross WL; Reinhold-Keller E
    Rheumatology (Oxford); 2004 Mar; 43(3):315-20. PubMed ID: 14963200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis.
    Metzler C; Miehle N; Manger K; Iking-Konert C; de Groot K; Hellmich B; Gross WL; Reinhold-Keller E;
    Rheumatology (Oxford); 2007 Jul; 46(7):1087-91. PubMed ID: 17519271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.
    Pagnoux C; Mahr A; Hamidou MA; Boffa JJ; Ruivard M; Ducroix JP; Kyndt X; Lifermann F; Papo T; Lambert M; Le Noach J; Khellaf M; Merrien D; Puéchal X; Vinzio S; Cohen P; Mouthon L; Cordier JF; Guillevin L;
    N Engl J Med; 2008 Dec; 359(26):2790-803. PubMed ID: 19109574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide.
    Knight A; Askling J; Granath F; Sparen P; Ekbom A
    Ann Rheum Dis; 2004 Oct; 63(10):1307-11. PubMed ID: 15130900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved outcome in Wegener's granulomatosis and microscopic polyangiitis? A retrospective analysis of 95 cases in two cohorts.
    Eriksson P; Jacobsson L; Lindell A; Nilsson JA; Skogh T
    J Intern Med; 2009 Apr; 265(4):496-506. PubMed ID: 19141094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors at diagnosis of a first Wegener's granulomatosis relapse after obtaining complete remission.
    Pierrot-Deseilligny Despujol C; Pouchot J; Pagnoux C; Coste J; Guillevin L
    Rheumatology (Oxford); 2010 Nov; 49(11):2181-90. PubMed ID: 20675708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy.
    Thorne JE; Woreta FA; Jabs DA; Anhalt GJ
    Ophthalmology; 2008 Dec; 115(12):2146-2152.e1. PubMed ID: 18930554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.